Dimensional Fund Advisors LP Acquires 11,602 Shares of Xylem Inc. $XYL

Dimensional Fund Advisors LP increased its holdings in Xylem Inc. (NYSE:XYLFree Report) by 0.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,048,035 shares of the industrial products company’s stock after buying an additional 11,602 shares during the period. Dimensional Fund Advisors LP’s holdings in Xylem were worth $244,699,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of XYL. Wexford Capital LP bought a new stake in shares of Xylem during the 3rd quarter valued at $27,000. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem during the fourth quarter valued at about $27,000. Entrust Financial LLC purchased a new stake in shares of Xylem in the fourth quarter worth about $45,000. FWL Investment Management LLC bought a new position in shares of Xylem in the second quarter valued at approximately $43,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Xylem during the fourth quarter valued at approximately $45,000. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Up 0.7%

XYL opened at $117.00 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The stock has a market cap of $27.81 billion, a PE ratio of 29.11, a PEG ratio of 1.65 and a beta of 1.03. The business has a 50 day moving average of $113.81 and a 200-day moving average of $122.84.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the prior year, the firm posted $1.03 EPS. Xylem’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts predict that Xylem Inc. will post 5.52 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Analyst Ratings Changes

Several research firms have recently weighed in on XYL. Royal Bank Of Canada upped their price target on shares of Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a report on Thursday, July 16th. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. dropped their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, April 16th. Finally, Stifel Nicolaus dropped their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a report on Monday. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $153.15.

Get Our Latest Report on XYL

Insider Activity

In related news, Director Jerome A. Peribere bought 1,210 shares of the stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.32% of the company’s stock.

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.